MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Accurately distinguishing between different degenerative dementias during life is challenging but increasingly important with the prospect of disease-modifying therapies. Molecular biomarkers of dementia pathology are becoming available, but are not widely used in clinical practice. Conversely, structural neuroimaging is recommended in the evaluation of cognitive impairment. Visual assessment remains the primary method of scan interpretation, but in the absence of a structured approach, diagnostically relevant information may be under-utilized. This definitive, multi-centre study uses post-mortem confirmed cases as the gold standard to: (i) assess the reliability of six visual rating scales; (ii) determine their associated pattern of atrophy; (iii) compare their diagnostic value with expert scan assessment; and (iv) assess the accuracy of a machine learning approach based on multiple rating scales to predict underlying pathology. The study includes T1-weighted images acquired in three European centres from 184 individuals with histopathologically confirmed dementia (101 patients with Alzheimer's disease, 28 patients with dementia with Lewy bodies, 55 patients with frontotemporal lobar degeneration), and scans from 73 healthy controls. Six visual rating scales (medial temporal, posterior, anterior temporal, orbito-frontal, anterior cingulate and fronto-insula) were applied to 257 scans (two raters), and to a subset of 80 scans (three raters). Six experts also provided a diagnosis based on unstructured assessment of the 80-scan subset. The reliability and time taken to apply each scale was evaluated. Voxel-based morphometry was used to explore the relationship between each rating scale and the pattern of grey matter volume loss. Additionally, the performance of each scale to predict dementia pathology both individually and in combination was evaluated using a support vector classifier, which was compared with expert scan assessment to estimate clinical value. Reliability of scan assessment was generally good (intraclass correlation coefficient > 0.7), and average time to apply all six scales was <3 min. There was a very close association between the pattern of grey matter loss and the regions of interest each scale was designed to assess. Using automated classification based on all six rating scales, the accuracy (estimated using the area under the receiver-operator curves) for distinguishing each pathological group from controls ranged from 0.86-0.97; and from one another, 0.75-0.92. These results were substantially better than the accuracy of any single scale, at least as good as expert reads, and comparable to previous studies using molecular biomarkers. Visual rating scores from magnetic resonance images routinely acquired as part of the investigation of dementias, offer a practical, inexpensive means of improving diagnostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Visual assessment of scans using rating scales are reliable and offer diagnostic accuracy equivalent or better to unstructured scan evaluation by expert raters with an area under the curve (AUC) ranging from 0.67 to 0.97 for the differential diagnosis of different types of dementia [11, 13].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016 · cited 2×
“SVC processing and analysis was performed using the Python libraries SciPy 0.14.0 (Jones et al., 2001) and Scikit-Learn 0.15.2 (Pedregosa et al., 2011).”
MethodInfluentialIntraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532 · cited 1×
“As described by Shrout and Fleiss (1979), there are several forms of ICC, with the appropriate form determined by the underlying statistical model and the intended application of the reliability results.”
BackgroundData Structures for Statistical Computing in Python
McKinney, W. (2010) · Proceedings of the Python in Science Conference · doi:10.25080/majora-92bf1922-00a · Cited by 11,032 · cited 2×
“The time taken by each rater to apply the visual rating protocol to each image was automatically recorded to estimate the feasibility of implementing such a protocol in clinical practice.”
MethodInfluentialCortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910 · cited 8×
“This large, multi-centre study of pathologically proven dementias demonstrates that visual rating scales from routinely acquired structural MRIs are fairly reliable and highly correlated with cerebral atrophy in brain regions vulnerable to dementia pathology.”
MethodInfluentialThe NumPy Array: A Structure for Efficient Numerical Computation
van der Walt, S., Colbert, S. C., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.37 · Cited by 9,381 · cited 1×
“All data processing and analyses were performed using Python libraries NumPy 1.8.1 (van der Walt et al., 2011), SciPy 0.14.0 (Jones et al., 2001) and Pandas 0.14.1 (McKinney, 2010) on Python 2.7.6 – 64-bit.”
MethodInfluentialA fast diffeomorphic image registration algorithm
Ashburner, J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.007 · Cited by 8,122 · cited 2×
“A group average tissue probability map was generated through iterative alignment of the initial segmentations to an evolving estimate of their group-wise average using the Dartel toolbox (Ashburner, 2007; Ashburner and Friston, 2009).”
MethodAshburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507 · cited 2×
“Cognitively normal control subjects (n = 73) were also included in the study.”
InfluentialSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 2×
“By contrast, structural neuroimaging is widely available and recommended as part of the clinical evaluation in all patients with suspected dementia [National Collaborating Centre for Mental Health (UK), 2006] and in the diagnostic criteria for a number of different dementias (Hort et al., 2010; Gorno-Tempini et al., 2…”
BackgroundSelf-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141 · cited 2×
“By contrast, structural neuroimaging is widely available and recommended as part of the clinical evaluation in all patients with suspected dementia [National Collaborating Centre for Mental Health (UK), 2006] and in the diagnostic criteria for a number of different dementias (Hort et al., 2010; Gorno-Tempini et al., 2…”
BackgroundSelf-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citation
Research works printed but not linked: 1
- Fumagalli, 2014, 9th International Conference on Frontotemporal Dementias P.252 Development of a visual rating scale for atrophy of the anterior cingulate, insula and frontal lobes, Am J Neurodegener Dis, 3, 1
Cited by
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Self-citationDiagnosis and Management of Dementia: Review
Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019) · JAMA · doi:10.1001/jama.2019.4782 · Cited by 1,403
Topiwala, A., Allan, C. L., Valkanova, V., Zsoldos, E., Filippini, N., Sexton, C., Mahmood, A., Fooks, P., Singh-Manoux, A., Mackay, C. E., et al. (2017) · BMJ · doi:10.1136/bmj.j2353 · Cited by 455
Amsterdam Dementia Cohort: Performing Research to Optimize Care
van der Flier, W. M., & Scheltens, P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170850 · Cited by 390
“performing scale in diagnosing AD [13].”
Self-citationDementia with Lewy bodies: an update and outlook
Outeiro, T. F., Koss, D. J., Erskine, D., Walker, L., Kurzawa-Akanbi, M., Burn, D., Donaghy, P., Morris, C., Taylor, J.-P., Thomas, A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0306-8 · Cited by 381
“DLB is associated with less severe medial temporal lobe atrophy on structural imaging when compared to AD [56].”
BackgroundDucharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., van den Stock, J., Dallaire-Théroux, C., Seelaar, H., Gossink, F., Vijverberg, E., et al. (2020) · Brain · doi:10.1093/brain/awaa018 · Cited by 320
Ferreira, D., Verhagen, C., Hernández-Cabrera, J. A., Cavallin, L., Guo, C.-J., Ekman, U., Muehlboeck, J.-S., Simmons, A., Barroso, J., Wahlund, L.-O., et al. (2017) · Scientific Reports · doi:10.1038/srep46263 · Cited by 226
“Visual rating scales are quick and easy to use, and are the primary method for assessing brain structural changes in clinical settings 18–21 .”
InfluentialAghourian, M., Legault-Denis, C., Soucy, J.-P., Rosa-Neto, P., Gauthier, S., Kostikov, A., Gravel, P., & Bédard, M.-A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.183 · Cited by 220
Imaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
Self-citationThe use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
“Visual assessment of scans using rating scales are reliable and offer diagnostic accuracy equivalent or better to unstructured scan evaluation by expert raters with an area under the curve (AUC) ranging from 0.67 to 0.97 for the differential diagnosis of different types of dementia [11, 13].”
MethodInfluentialSelf-citationSemantic dementia and the left and right temporal lobes
Snowden, J. S., Harris, J. M., Thompson, J. C., Kobylecki, C., Jones, M., Richardson, A. M., & Neary, D. (2018) · Cortex · doi:10.1016/j.cortex.2017.08.024 · Cited by 140
Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects
Ahmed, M. R., Zhang, Y., Feng, Z., Lo, B., Inan, O. T., & Liao, H. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2018.2886237 · Cited by 142
“In [69], six MRI visual rating scales were applied to collect T1-weighted images of confirmed dementia with the AD, DLB, and FTD.”
MethodPatterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
Harper, L., Bouwman, F., Burton, E. J., Barkhof, F., Scheltens, P., O’Brien, J. T., Fox, N. C., Ridgway, G. R., & Schott, J. M. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314978 · Cited by 129
Self-citationLong COVID‐19: Objectifying most self‐reported neurological symptoms
Bungenberg, J., Humkamp, K., Hohenfeld, C., Rust, M. I., Ermis, U., Dreher, M., Hartmann, N. K., Marx, G., Binkofski, F., Finke, C., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51496 · Cited by 144
“This is a not a novel association but adds to the amount of literature, including a meta-analysis of neuroimaging findings of 2125 patients during acute COVID-19 showing that ICU care was associated with significantly higher incidences of microvascular pathology, with a predilection for the corpus callosum, cerebral m…”
ResultImaging biomarkers of dementia: recommended visual rating scales with teaching cases
From the Imaging Cognitive Impairment Network (ICINET), Wahlund, L., Westman, E., van Westen, D., Wallin, A., Shams, S., Cavallin, L., & Larsson, E. (2016) · Insights into Imaging · doi:10.1007/s13244-016-0521-6 · Cited by 128
Beyond the average patient: how neuroimaging models can address heterogeneity in dementia
Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106
Self-citationDementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design
Toledo, J. B., Ruiz, C. A., Weil, R. S., Ferreira, D., Rodriguez‐Porcel, F. E., Pilotto, A., Wyman‐Chick, K. A., Grothe, M. J., Kane, J. P. M., Taylor, A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12814 · Cited by 121
Oppedal, K., Ferreira, D., Cavallin, L., Lemstra, A. W., ten Kate, M., Padovani, A., Rektorová, I., Bonanni, L., Wahlund, L., Engedal, K., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.09.011 · Cited by 98
“These visual rating scales are quick and easy to use and are the primary method for assessing brain structural changes in a clinical setting [12,13].”
Young‐onset dementia diagnosis, management and care: a narrative review
Loi, S. M., Cations, M., & Velakoulis, D. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.51849 · Cited by 112
Khedher, L., Illán, I. A., Górriz, J. M., Ramírez, J., Brahim, A., & Meyer-Baese, A. (2017) · International Journal of Neural Systems · doi:10.1142/s0129065716500507 · Cited by 92
Vijverberg, E. G. B., Wattjes, M. P., Dols, A., Krudop, W. A., Möller, C., Peters, A., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160285 · Cited by 92
Self-citationNeuroimaging in Lewy body dementia
Yousaf, T., Dervenoulas, G., Valkimadi, P.-E., & Politis, M. (2019) · Journal of Neurology · doi:10.1007/s00415-018-8892-x · Cited by 87
Sheng, C., Yang, K. Y., He, B., Du, W., Cai, Y., & Han, Y. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00977-x · Cited by 94
“Thirdly, in our study, not all the CI patients had amyloid-PET data, and the diagnosis of MCI and AD was mainly based on the clinical practice [58, 59].”
BackgroundVernooij, M. W., Pizzini, F. B., Schmidt, R., Smits, M., Yousry, T. A., Bargalló, N., Frisoni, G. B., Haller, S., & Barkhof, F. (2019) · Neuroradiology · doi:10.1007/s00234-019-02188-y · Cited by 86
Self-citationApplying the ATN scheme in a memory clinic population: The ABIDE project
Altomare, D., de Wilde, A., Ossenkoppele, R., Pelkmans, W., Bouwman, F., Groot, C., van Maurik, I., Zwan, M., Yaqub, M., Barkhof, F., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008361 · Cited by 79
Self-citationThe A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment
Ekman, U., Ferreira, D., & Westman, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-26151-8 · Cited by 78
Pistollato, F., Ohayon, E. L., Lam, A., Langley, G. R., Novak, T. J., Pamies, D., Perry, G., Trushina, E., Williams, R. S. B., Roher, A. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9175 · Cited by 77
“Moreover, as clinical studies of AD attempt to discover earlier and more sensitive biomarkers, neuropathology studies remain the key reference for validation [88].”
Backgroundten Kate, M., Barkhof, F., Boccardi, M., Visser, P. J., Jack, C. R., Lövblad, K., Frisoni, G. B., & Scheltens, P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.05.024 · Cited by 85
“Other imaging markers such as parietal or frontal atrophy may be more useful in differentiating between Alzheimer’s disease and other underlying pathologies (Harper et al., 2016, 2015; Koedam et al., 2011; Lehmann et al., 2012; Vemuri et al., 2011).”
Self-citationDetecting frontotemporal dementia syndromes using MRI biomarkers
Bruun, M., Koikkalainen, J., Rhodius-Meester, H. F. M., Baroni, M., Gjerum, L., van Gils, M., Soininen, H., Remes, A. M., Hartikainen, P., Waldemar, G., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101711 · Cited by 75
“For detection of FTD using API we therefore aimed for a high specificity with the trade-off of a moderate-low sensitivity, although still comparable to other MRI derived biomarkers with lower specificity (Bouts et al., 2018; Harper et al., 2016; Muñoz-Ruiz et al., 2012; Steketee et al., 2016a).”
Self-citationClaus, J. J., Staekenborg, S. S., Holl, D. C., Roorda, J. J., Schuur, J., Koster, P., Tielkes, C. E. M., & Scheltens, P. (2017) · European Radiology · doi:10.1007/s00330-016-4726-3 · Cited by 83
Self-citationClinical Guidelines for Cognitive Disorders in Elderly and Older Patients
Bogolepova, A. N., Васенина, Е. Е., Gomzyakova, N. A., Gusev, E. I., Dudchenko, N. G., Emelin, А. Y., Zalutskaya, N. M., Isaev, R. I., Kotovskaya, Y. V., Levin, O. S., et al. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20211211036 · Cited by 79
Dementia with Lewy bodies: Challenges in the diagnosis and management
Chin, K. S., Teodorczuk, A., & Watson, R. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419835029 · Cited by 63
“One study with autopsy validation found that using MRI visual rating scale, medial temporal lobe atrophy differentiated AD from DLB with a sensitivity of 64% and specificity of 68% (Harper et al., 2016).”
BackgroundMRI-based evaluation of structural degeneration in the ageing brain: Pathophysiology and assessment
Grajauskas, L. A., Siu, W. W. Y., Medvedev, G., Guo, H., D’Arcy, R. C. N., & Song, X. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.004 · Cited by 66
Fink, H. A., Linskens, E. J., Silverman, P. C., McCarten, J. R., Hemmy, L. S., Ouellette, J. M., Greer, N. L., Wilt, T. J., & Butler, M. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3888 · Cited by 57
“04, respectively, for distinguishing late-onset AD from FTLD-TDP43 (n = 28) (34).”
(GENFI), O. B. O. T. G. F. I., Fumagalli, G., Basilico, P., Arighi, A., Bocchetta, M., Dick, K. M., Cash, D. M., Harding, S. R., Mercurio, M., Fenoglio, C., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0376-9 · Cited by 61
“The protocol made use of previously validated scales with particular attention to areas known to show atrophy in FTD [13].”
BackgroundMethodInfluentialSelf-citationRay, P. P., Dash, D., & De, D. (2019) · Journal of Medical Systems · doi:10.1007/s10916-019-1417-z · Cited by 57
Structural MRI profiles and tau correlates of atrophy in autopsy-confirmed CTE
Alosco, M. L., Mian, A. Z., Buch, K. A., Farris, C. W., Uretsky, M., Tripodis, Y., Baucom, Z., Martin, B. M., Palmisano, J. N., Puzo, C. J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00928-y · Cited by 61
“We examined the MRI patterns of CTE by comparing visually rated macrostructural features (using established visual rating scales) on antemortem MRIs in brain donors with autopsy-confirmed CTE, all of whom were reported to be symptomatic, and participants with normal cognition (NC) (deceased and living, only six of who…”
MethodResultInfluentialBiomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
Bousiges, O., & Blanc, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126371 · Cited by 68
Nicolini, P., Mari, D., Abbate, C., Inglese, S., Bertagnoli, L., Tomasini, E., Rossi, P. D., & Lombardi, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-68131-x · Cited by 50
The quantitative neuroradiology initiative framework: application to dementia
Goodkin, O., Pemberton, H., Vos, S. B., Prados, F., Sudre, C. H., Moggridge, J. C., Cardoso, M. J., Ourselin, S., Bisdas, S., White, M. J., et al. (2019) · British Journal of Radiology · doi:10.1259/bjr.20190365 · Cited by 50
Self-citationBottani, S., Burgos, N., Maire, A., Wild, A., Ströer, S., Dormont, D., & Colliot, O. (2021) · Medical Image Analysis · doi:10.1016/j.media.2021.102219 · Cited by 63
Falgàs, N., Sánchez-Valle, R., Bargalló, N., Balasa, M., Fernández-Villullas, G., Bosch, B., Olives, J., Tort-Merino, A., Antonell, A., Muñoz-García, C., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101927 · Cited by 47
“(Harper et al., 2016) This could be explained by the characteristics of our older HC group in whom preclinical AD had been carefully ruled out through the use of CSF biomarkers and an extensive neuropsychological evaluation.”
BackgroundMethodMcCarthy, J., Collins, D. L., & Ducharme, S. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.08.028 · Cited by 47
Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART)
Quintas-Neves, M., Teylan, M., Besser, L. M., Soares-Fernandes, J. P., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0842-z · Cited by 50
Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers
Ferreira, D., Jelić, V., Cavallin, L., Oeksengaard, A., Snædal, J., Høgh, P., Andersen, B. B., Naik, M., Engedal, K., Westman, E., et al. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000448394 · Cited by 45
Pemberton, H., Goodkin, O., Prados, F., Das, R., Vos, S. B., Moggridge, J. C., Coath, W., Gordón, E., Barrett, R., Schmitt, A., et al. (2021) · European Radiology · doi:10.1007/s00330-020-07455-8 · Cited by 44
Self-citationKautzky, A., Seiger, R., Hahn, A., Fischer, P. A., Krampla, W. W., Kasper, S. F., Kovács, G. G., & Lanzenberger, R. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00406 · Cited by 46
“Nevertheless, only one prediction model for neuropathologically verified dementias has been proposed yet (Harper et al., 2016).”
BackgroundHedderich, D. M., Dieckmeyer, M., Andrisan, T., Ortner, M., Grundl, L., Schön, S., Suppa, P., Finck, T., Kreiser, K., Zimmer, C., et al. (2020) · European Radiology · doi:10.1007/s00330-019-06602-0 · Cited by 42
“In the past, semi-quantitative visual rating scales—most prominently the mesial temporal atrophy (MTA) score—have been shown to increase interrater reliability [4, 35, 36].”
BackgroundAutomatically computed rating scales from MRI for patients with cognitive disorders
Initiative, A. D. N., Koikkalainen, J. R., Rhodius‐Meester, H. F. M., Frederiksen, K. S., Bruun, M., Hasselbalch, S. G., Baroni, M., Mecocci, P., Vanninen, R. L., Remes, A. M., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06067-1 · Cited by 47
Self-citationSakurai, K., Tokumaru, A. M., Ikeda, T., Morimoto, S., Inui, S., Sumida, K., Oba, H., Nakagawa, M., Matsukawa, N., & Hashizume, Y. (2019) · Neuroradiology · doi:10.1007/s00234-019-02247-4 · Cited by 41
Li, W.-W., Shen, Y.-Y., Tian, D.-Y., Bu, X.-L., Zeng, F., Liu, Y.-H., Chen, Y., Yao, X.-Q., Li, H.-Y., Chen, D.-W., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190056 · Cited by 39
Longo, M. G. F., Conklin, J., Cauley, S., Setsompop, K., Tian, Q., Polak, D., Polackal, M. N., Splitthoff, D. N., Liu, W., González, R. G., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6703 · Cited by 40
Wittens, M. M. J., Allemeersch, G., Sima, D. M., Naeyaert, M., Vanderhasselt, T., Vanbinst, A., Buls, N., Brucker, Y. D., Raeymaekers, H., Fransén, E., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.746982 · Cited by 44
García-Gutierrez, F., Díaz-Álvarez, J., Matias-Guiu, J. A., Pytel, V., Matías-Guiu, J., Cabrera-Martín, M. N., & Ayala, J. L. (2022) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-022-02630-z · Cited by 38
“Focusing on neurodegenerative diseases and Python - developed studies, [29] performed a ML-based analysis to perform data-driven diagnosis of dementia and used post-mortem confirmed cases as a gold-standard; [43] implemented a pipeline based on a DeepSymNet architecture to detect the AD progression…”
Naming and conceptual understanding in frontotemporal dementia
Snowden, J. S., Harris, J., Saxon, J. A., Thompson, J. C., Richardson, A. M. T., Jones, M. S., & Kobylecki, C. (2019) · Cortex · doi:10.1016/j.cortex.2019.04.027 · Cited by 44
Frontotemporal Dementia – Current Concepts
Puppala, G. K., Gorthi, S. P., Chandran, V., & Gundabolu, G. (2021) · Neurology India · doi:10.4103/0028-3886.329593 · Cited by 44
Borroni, B., Benussi, A., Premi, E., Alberici, A., Marcello, E., Gardoni, F., Di Luca, M., & Padovani, A. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170584 · Cited by 36
Vernooij, M. W., Jasperse, B., Steketee, R. M. E., Koek, M., Vrooman, H. A., Ikram, M. A., Papma, J. M., van der Lugt, A., Smits, M., & Niessen, W. J. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.004 · Cited by 37
“(Harper et al., 2016) found a high correlation between regional visual scales and voxel-based morphometry (VBM).”
BackgroundGossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00757 · Cited by 34
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders
Pilotto, A., Romagnolo, A., Scalvini, A., Masellis, M., Shimo, Y., Bonanni, L., Camicioli, R. M., Wang, L., Dwivedi, A. K., Longardner, K., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012342 · Cited by 40
Disease- and stage-specific alterations of the oral and fecal microbiota in Alzheimer's disease
Troci, A., Philippen, S., Rausch, P., Rave, J., Weyland, G., Niemann, K., Jessen, K., Schmill, L.-P. A., Aludin, S., Franke, A., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad427 · Cited by 36
“The score ranges from 0 (no mediotemporal atrophy) to 4 (severe loss of mediotemporal volume) and was validated for diagnosis of AD in a research context (106).”
MethodClinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia
Orso, B., Mattei, C., Arnaldi, D., Massa, F., Serafini, G., Plantone, D., Doglione, E., Grafman, J. H., Nobili, F. M., & Pardini, M. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.12.007 · Cited by 38
Fumagalli, G., Basilico, P., Arighi, A., Mercurio, M., Scarioni, M., Carandini, T., Colombi, A., Pietroboni, A. M., Sacchi, L., Conte, G., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102453 · Cited by 35
“Instead of comparing groups, we preferred to run a correlation analysis to obtain a more tailored correspondence with the area observed (Figure 3), as already been shown in previous studies(Fumagalli et al., 2018; Harper et al., 2016).”
MethodSelf-citationBousiges, O., Philippi, N., Lavaux, T., Perret‐Liaudet, A., Lachmann, I., Schaeffer‐Agalède, C., Anthony, P., Botzung, A., Rauch, L., Jung, B., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00684-5 · Cited by 37
The current status of blood epigenetic biomarkers for dementia
Fransquet, P., & Ryan, J. L. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1639129 · Cited by 31
Illán‐Gala, I., Falgàs, N., Friedberg, A., Castro‐Suárez, S., Keret, O., Rogers, N., Öz, D., Nigro, S. L., Quattrone, A., Quattrone, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1290 · Cited by 27
Predicting the Prognosis of MCI Patients Using Longitudinal MRI Data
Er, F. C., & Goularas, D. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3017872 · Cited by 29
“By consequence, the use of computational models for the definition of biomarkers can contribute significantly to the prognosis prediction for MCI patients [15].”
O’Shea, D. M., Arkhipenko, A., Galasko, D. R., Goldman, J. G., Sheikh, Z. H., Petrides, G. S., Toledo, J. B., & Galvin, J. E. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1395413 · Cited by 28
Medial temporal lobe atrophy and posterior atrophy scales normative values
Ramusino, M. C., Altomare, D., Bacchin, R. A., Ingala, S., Bnà, C., Bonetti, M., Costa, A. C., Barkhof, F., Nicolosi, V., Festari, C., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101936 · Cited by 24
“These scales demonstrated a similar accuracy in distinguishing healthy controls from subjects affected by dementia, especially due to AD, as automated measurement methods (Scheltens et al., 1992; Harper et al., 2016).”
Self-citationEvaluation of MR Visual Rating Scales in Major Forms of Dementia
Kaushik, S., Vani, K., Chumber, S., Anand, K. S., & Dhamija, R. K. (2020) · Journal of Neurosciences in Rural Practice · doi:10.1055/s-0040-1716806 · Cited by 30
Kashyap, K., & Siddiqi, M. I. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10274-8 · Cited by 24
Recent Advances in Frontotemporal Dementia
Tartaglia, M. C., & Mackenzie, I. R. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.69 · Cited by 27
Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis
Cajanus, A., Hall, A., Koikkalainen, J., Solje, E., Tolonen, A., Urhemaa, T., Liu, Y., Haanpää, R. M., Hartikainen, P., Helisalmi, S., et al. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000486849 · Cited by 23
“However, visual evaluation of magnetic resonance imaging (MRI) requires an experienced neuroradiologist , and even so, the visual assessment provides only 59% sensitivity and 80% specificity from other common diseases and is vulnerable for inter-rater differences [7].”
Identifying brain changes related to cognitive aging using VBM and visual rating scales
Pergher, V., Demaerel, P., Soenen, O., Saarela, C., Tournoy, J., Schoenmakers, B., Karrasch, M., & Hulle, M. M. V. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101697 · Cited by 29
“Our use of both visual rate scale and VBM analysis was motivated by the study of Harper et al. (2016) who correlated 6 visual rating scales of atrophy level and whole brain VBM grey matter volume in (post-mortem) dementia patients, but different from those studies where the brain volume analysis…”
Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment
Falgàs, N., Balasa, M., Bargalló, N., Borrego‐Écija, S., Ramos‐Campoy, O., Fernández‐Villullas, G., Bosch, B., Olives, J., Tort‐Merino, A., Antonell, A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191167 · Cited by 23
Creation of an anthropomorphic CT head phantom for verification of image segmentation
Holmes, R. B., Negus, I. S., Wiltshire, S. J., Thorne, G. C., Young, P., & Initiative, T. A. D. N. (2020) · Medical Physics · doi:10.1002/mp.14127 · Cited by 26
“19 The accuracy and precision of these methods have not been well characterized.”
Cerebrovascular and Alzheimer’s disease biomarkers in dementia with Lewy bodies and other dementias
Rennie, A., Ekman, U., Shams, S., Rydén, L., Samuelsson, J., Zettergren, A., Kern, S., Oppedal, K., Blanc, F., Hort, J., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae290 · Cited by 24
Zhu, H., Lu, H., Wang, F., Liu, S., Shi, Z., Gan, J., Du, X., Yang, Y., Li, D., Wang, L., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.779344 · Cited by 23
“Therefore, it is necessary to combine the MTA scale with other visual rating scales to improve the accuracy of diagnosis (19).”
MethodVoxel-wise deviations from healthy aging for the detection of region-specific atrophy
Klöppel, S., Yang, S., Kellner, E., Reisert, M., Heimbach, B., Urbach, H., Linn, J., Weidauer, S., Andres, T., Bröse, M., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.09.013 · Cited by 22
Li, P., Quan, W., Wang, Z., Liu, Y., Cai, H., Chen, Y., Wang, Y., Zhang, M., Tian, Z., Zhang, H., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.981451 · Cited by 20
“Traditional visual assessment of brain MRI requires the time of an well-experienced neuroradiologist and provides only moderate sensitivity and specificity (Harper et al., 2016).”
BackgroundSheng, C., Xia, M., Yu, H., Huang, Y. M., Lu, Y., Liu, F., He, Y., & Han, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179823 · Cited by 21
Yuan, Z., Pan, C., Xiao, T., Liu, M., Zhang, W., Jiao, B., Yan, X., Tang, B., & Shen, L. H. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00093 · Cited by 22
“Given that there was research taking 65 years old as the cutoff point in the process of combining six visual rating scales to diagnose AD (15), our study divided AD cases into two groups (early-onset AD and late-onset AD) and enrolled age as a variate into the research model to be selected.”
BackgroundMethodResultInfluentialThe Entorhinal Cortex Atrophy Score Is Diagnostic and Prognostic in Mild Cognitive Impairment
Traschütz, A., Enkirch, S. J., Polomac, N., Widmann, C. N., Schild, H. H., Heneka, M. T., & Hattingen, E. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-181150 · Cited by 23
Clinical guidelines «Cognitive disorders in the elderly and senile persons»
Tkacheva, O. N., Yahno, N. N., Незнанов, Н. Г., Шпорт, С. В., Shamalov, N. A., Levin, O. S., Kostyuk, G. P., Gusev, E. I., Martynov, M. Y., Si, G., et al. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2025125337 · Cited by 23
Orad, R. I., & Shiner, T. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10402-2 · Cited by 26
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia
Benussi, A., Premi, E., Grassi, M., Alberici, A., Cantoni, V., Gazzina, S., Archetti, S., Gasparotti, R., Fumagalli, G., Bouzigues, A., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01383-1 · Cited by 21
“…particularly during the conversion from the presymptomatic to symptomatic phase, even if not specific for the disease [7, 35, 36], and anterior cingulate cortex atrophy, which is scored easily by visual rating scales at single subject level and has been shown to be specific for FTD [25, 37, 38].”
BackgroundMethodResultInfluentialSelf-citationNeuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility
Dev, S. I., Dickerson, B. C., & Touroutoglou, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_7 · Cited by 18
Mai, Y., Yu, Q., Zhu, F., Luo, Y., Liao, W., Zhao, L., Xu, C., Fang, W., Ruan, Y., Cao, Z., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201033 · Cited by 19
Quintas-Neves, M., Teylan, M., Morais‐Ribeiro, R., Almeida, F., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.04.013 · Cited by 19
Chen, X., Tang, M., Liu, A., & Wei, X. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2961 · Cited by 19
Brzezicki, M. A., Kobetić, M. D., Neumann, S., & Pennington, C. M. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.03.002 · Cited by 19
“…that artificial intelligence (AI)-developed methods of imaging analysis and pattern recognition can reliably improve the diagnostic accuracy when compared to a human-based assessment (e.g. in classification of fractures [33], dermatological assessment [34], or MRI interpretation [35– 39]).”
MethodZdanovskis, N., Platkājis, A., Kostiks, A., Šneidere, K., Stepens, A., Naglis, R., & Karelis, G. (2022) · Medicina · doi:10.3390/medicina58070887 · Cited by 19
“In general, it is a necessity to identify valuable imaging biomarkers and develop visual rating scales for the evaluation of cognitive impairment, including microvascular biomarkers [41,42].”
BackgroundVisual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort
Loreto, F., Gontsarova, A., Scott, G., Patel, N., Win, Z., Carswell, C. J., Perry, R. J., & Malhotra, P. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51749 · Cited by 20
“Other researchers, instead, have established different cut-off scores according to clinical populations rather than age groups.(14,15) Moreover, studies have differed in the way they analyzed the left and right hemisphere scores, with some using the sum, others the highest score, while the majority incorporated the me…”
BackgroundMethodResultInfluentialSakurai, K., Kaneda, D., Morimoto, S., Uchida, Y., Inui, S., Kimura, Y., Kan, H., Kato, T., Ito, K., & Hashizume, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230068 · Cited by 17
Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration
Duignan, J. A., Haughey, A. M., Kinsella, J. A., & Killeen, R. P. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.002 · Cited by 18
MRI of non-Alzheimer's dementia: current and emerging knowledge
Filippi, M., & Agosta, F. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000571 · Cited by 18
Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
Katisko, K., Cajanus, A., Korhonen, T., Remes, A. M., Haapasalo, A., & Solje, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00658 · Cited by 22
“Visual assessment of brain MRI results requires an experienced neuroradiologist and is time consuming, yet it provides only moderate sensitivity and specificity (Harper et al., 2016).”
BackgroundTremor-Dominant Cervical Dystonia: a Cerebellar Syndrome
Mahajan, A., Schroder, L., Rekhtman, A., Dwivedi, A. K., Wang, L., & Espay, A. J. (2020) · The Cerebellum · doi:10.1007/s12311-020-01211-w · Cited by 15
Structural and Functional Magnetic Resonance Imaging of Dementia With Lewy Bodies
Balážová, Z., Novàkovâ, M., Minsterová, A. Š., & Rektorová, I. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.10.005 · Cited by 16
Philippen, S., Hanert, A., Schönfeld, R., Granert, O., Yılmaz, R., Jensen‐Kondering, U., Splittgerber, M., Moliadze, V., Siniatchkin, M., Berg, D., et al. (2023) · Clinical Neurophysiology · doi:10.1016/j.clinph.2023.11.003 · Cited by 20
Metadata
- Authors
- Harper, L., Fumagalli, G. G., Barkhof, F., Scheltens, P., O’Brien, J. T., Bouwman, F., Burton, E. J., Rohrer, J. D., Fox, N. C., Ridgway, G. R., & Schott, J. M.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- University of Milan (IT)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Newcastle Hospitals - Campus for Ageing and Vitality (GB)
- Wellcome Centre for Human Neuroimaging (GB)
- Corresponding author
- Schott, Jonathan M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-01
- Volume
- 139
- Issue
- 4
- Pages
- 1211-1225
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC4806219
- OpenAlex
- W2289713178
- Cited by
- 264
- References
- 60
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 30 · 2023: 21 · 2022: 28 · 2021: 33 · 2020: 34 · 2019: 33 · 2018: 16 · 2017: 18 · 2016: 7
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Brain (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10134, NF-SI-0508-10123, CL-2012-18-010)
- Medical Research Council (MR/J014257/2, MR/M008525/1)
- Engineering and Physical Sciences Research Council (EP/J020990/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiology practices and education
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia diagnosis, Alzheimer's disease, dementia with Lewy bodies, frontotemporal lobar degeneration, gray matter atrophy, T1-weighted imaging, rating scale reliability, machine learning classification, support vector classifier, postmortem histopathology, structural neuroimaging, disease-modifying therapy, molecular biomarkers, voxel-based morphometry
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Autopsy, Cerebral Cortex, Dementia, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Reproducibility of Results, Lewy Body Disease, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.